The prognosis of carcinoma of the breast in relation to the type of operation performed.
作者信息
PATEY D H, DYSON W H
出版信息
Br J Cancer. 1948 Mar;2(1):7-13. doi: 10.1038/bjc.1948.2.
Abstract
摘要
相似文献
1
The prognosis of carcinoma of the breast in relation to the type of operation performed.
Br J Cancer. 1948 Mar;2(1):7-13. doi: 10.1038/bjc.1948.2.
2
[MEDULLARY CARCINOMA OF THE BREAST WITH LYMPHOCYTIC INFILTRATIONS. (A POOR PROGNOSIS TYPE OF CARCINOMA)].
Med Glas. 1963 Feb;17:84-6.
3
4
The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.
Breast. 2012 Jun;21(3):289-95. doi: 10.1016/j.breast.2011.12.011. Epub 2012 Jan 25.
5
Prognosis in carcinoma of the breast.
Br J Radiol. 1948 Dec;21(252):594-6. doi: 10.1259/0007-1285-21-252-594.
6
Lymph-node involvement and prognosis in carcinoma of the breast.
Am J Clin Pathol. 1955 Nov;25(11):1298-9. doi: 10.1093/ajcp/25.11.1298.
7
[A case of spindle cell carcinoma of the breast including metaplastic lesion with poor prognosis].
Gan To Kagaku Ryoho. 2009 Jun;36(6):1017-9.
8
Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years.
Br Med J. 1970 Jul 25;3(5716):181-8. doi: 10.1136/bmj.3.5716.181.
9
Factors influencing survival in infiltrating lobular carcinoma of the breast.
Am Surg. 1993 Jul;59(7):405-9.
10
A PATHOLOGIST VIEWS DIAGNOSIS AND PROGNOSIS OF CARCINOMA OF THE BREAST.
Radiology. 1964 Aug;83:255-62. doi: 10.1148/83.2.255.
引用本文的文献
1
The Effects of Systemic Tranexamic Acid Administration on Drainage Volume, Duration of Drain Placement, and Length of Hospital Stay in Skin- and Nipple-Sparing Mastectomies with Immediate Expander-Based Breast Reconstruction.
J Clin Med. 2024 Oct 30;13(21):6507. doi: 10.3390/jcm13216507.
2
Retrospective Analysis: Preserving More Subcutaneous Tissue Shows no Increase the Risk of Breast Cancer Recurrence.
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241264843. doi: 10.1177/15330338241264843.
3
Chinese Society of Breast Surgery (CSBrS) Practice Guideline 2022.
Transl Breast Cancer Res. 2023 Jan 31;4:2. doi: 10.21037/tbcr-22-50. eCollection 2023.
4
Axillary Management: How Much Is Too Much?
Curr Oncol Rep. 2024 Jul;26(7):735-743. doi: 10.1007/s11912-024-01539-0. Epub 2024 May 15.
5
Parallel pathways: A chronicle of evolution in rectal and breast cancer surgery.
World J Gastrointest Oncol. 2024 Apr 15;16(4):1091-1096. doi: 10.4251/wjgo.v16.i4.1091.
6
Axillary nodal staging in breast cancer: what have we learned?
Clin Exp Metastasis. 2024 Aug;41(4):375-380. doi: 10.1007/s10585-023-10262-2. Epub 2024 Jan 13.
7
The prevalence and risk factors for physical impairments in Chinese post-cancer treated breast cancer survivors: a 4 years' cross-sectional study at a single center.
Sci Rep. 2023 Oct 27;13(1):18458. doi: 10.1038/s41598-023-45731-x.
8
Early breast cancer: concept and therapeutic review.
Rev Assoc Med Bras (1992). 2023 Aug 4;69(suppl 1):e2023S114. doi: 10.1590/1806-9282.2023S114. eCollection 2023.
9
Oncoplastic and reconstructive breast surgery.
Front Oncol. 2023 Jun 28;13:1176915. doi: 10.3389/fonc.2023.1176915. eCollection 2023.
10
Treatment Changes in Breast Cancer Management and De-Escalation of Breast Surgery.
Eur J Breast Health. 2023 Jul 3;19(3):186-190. doi: 10.4274/ejbh.galenos.2023.2023-6-2. eCollection 2023 Jul.
Zotero 插件